Who owns Sarepta Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SRPT from SEC Form 13F filings across 323 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 323 institutions disclosed 107.5M shares of Sarepta Therapeutics, Inc. worth $1.93B — about 102% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
323
13F holders
$1.93B
value, 2026 filers
102%
of shares outstanding (107.5M sh)
53
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SRPT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 19.0M | $341.3M | 0.0% | 18% | +28.7% |
| 2 | STATE STREET CORP | 8.9M | $160.2M | 0.0% | 8.5% | +34.8% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.4M | $150.5M | 0.0% | 7.9% | +26.2% |
| 4 | TWO SIGMA INVESTMENTS, LP | 4.6M | $82.6M | 0.1% | 4.4% | +0.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $82.5M | 0.0% | 4.4% | +0.3% |
| 6 | FIRST TRUST ADVISORS LP | 4.4M | $78.5M | 0.0% | 4.1% | +5.6% |
| 7 | AQR CAPITAL MANAGEMENT LLC | 4.3M | $76.9M | 0.0% | 4.1% | -32.8% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $49.8M | 0.0% | 2.6% | +39.4% |
| 9 | Erste Asset Management GmbH | 2.6M | $45.5M | 0.4% | 2.4% | -13.5% |
| 10 | MARSHALL WACE, LLP | 2.2M | $39.6M | 0.0% | 2.1% | +204.3% |
| 11 | MORGAN STANLEY | 2.2M | $39.6M | 0.0% | 2.1% | -15.2% |
| 12 | Aberdeen Group plc | 2.2M | $39.4M | 0.1% | 2.1% | -5.3% |
| 13 | BANK OF AMERICA CORP /DE/ | 2.1M | $36.9M | 0.0% | 2% | -4.2% |
| 14 | GOLDMAN SACHS GROUP INC | 2.0M | $36.7M | 0.0% | 1.9% | +89.4% |
| 15 | UBS Group AG | 1.6M | $29.2M | 0.0% | 1.5% | -27.2% |
| 16 | FEDERATED HERMES, INC. | 1.6M | $28.6M | 0.0% | 1.5% | -11.0% |
| 17 | NORTHERN TRUST CORP | 1.2M | $21.8M | 0.0% | 1.1% | +67.2% |
| 18 | MILLENNIUM MANAGEMENT LLC | 1.2M | $21.4M | 0.0% | 1.1% | -2.3% |
| 19 | T. Rowe Price Investment Management, Inc. | 1.2M | $20.8M | 0.0% | 1.1% | +2.0% |
| 20 | CITIGROUP INC | 1.2M | $20.8M | 0.0% | 1.1% | +0.6% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 1.1M | $20.2M | 0.0% | 1.1% | -32.7% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 980,321 | $17.6M | 0.0% | 0.9% | +23.9% |
| 23 | Connor, Clark & Lunn Investment Management Ltd. | 973,493 | $17.5M | 0.0% | 0.9% | -4.6% |
| 24 | Invesco Ltd. | 903,379 | $16.2M | 0.0% | 0.9% | +120.2% |
| 25 | Legal & General Group Plc | 877,627 | $15.8M | 0.0% | 0.8% | +1.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.